Home > Markets > Stocks > Glenmark pharmaceuticals > Financial Statements> Profit & Loss

Glenmark Pharmaceuticals Ltd Financial Statements

Profit & Loss Statement of Glenmark Pharmaceuticals Ltd

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Revenue 10,944 10,641 9,074 9,079
yoy growth (%) 2.85 17.30 (0.10) 20.10
Raw materials (3,699) (3,699) (3,039) (2,614)
As % of sales 33.80 34.80 33.50 28.80
Employee costs (2,344) (2,255) (1,872) (1,641)
As % of sales 21.40 21.20 20.60 18.10
Other costs (2,817) (2,989) (2,549) (2,788)
As % of sales 25.70 28.10 28.10 30.70
Operating profit 2,084 1,698 1,615 2,037
OPM 19 16 17.80 22.40
Depreciation (444) (417) (302) (264)
Interest expense (353) (377) (286) (237)
Other income 50.20 160 91.40 37.40
Profit before tax 1,338 1,063 1,119 1,572
Taxes (412) (320) (315) (383)
Tax rate (31) (30) (28) (24)
Minorities and other -- -- -- --
Adj. profit 926 743 804 1,190
Exceptional items 44.50 32.90 -- (81)
Net profit 970 776 804 1,109
yoy growth (%) 25 (3.50) (27) 49.20
NPM 8.86 7.29 8.86 12.20

Invest in at ZERO Delivery Brokerage. Join 22 Lac+ Happy Clients

Open ZERO Brokerage Demat Account